Jeevan Scientific

₹47.2 -0.8 | 1.6%

WEBSITE BSE:538837 NSE : JSTL 18 May, 12:50

Market Cap ₹73 Cr.

Stock P/E -25.4

P/B 1.5

Current Price ₹47.2

Book Value ₹ 31.2

Face Value 10

52W High ₹70.9

Dividend Yield 0%

52W Low ₹ 38.6

Edit Ratio

Jeevan Scientific Research see more...

Overview Inc. Year: 1999Industry: IT - Software

Jeevan Scientific Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Jeevan Scientific Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	19	21	12	10	8	10	8	10	8	10
Other Income	0	0	5	0	0	0	0	0	0	-0
Total Income	19	21	17	11	8	10	8	11	8	10
Total Expenditure	12	14	14	9	8	8	9	8	7	9
Operating Profit	7	7	3	1	-0	2	-1	2	1	1
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	1	1	1	1	1	1	1	1	1	1
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	5	6	2	0	-2	0	-2	1	-1	-1
Provision for Tax	2	2	1	-0	-0	0	-0	0	-0	-0
Profit After Tax	4	4	1	0	-1	0	-2	1	-1	-0
Adjustments	0	0	-0	0	0	0	0	0	0	0
Profit After Adjustments	4	4	1	0	-1	0	-2	1	-1	-0
Adjusted Earnings Per Share	2.4	2.8	0.4	0.3	-0.8	0	-1.5	0.3	-0.4	-0.3

Jeevan Scientific Profit & Loss

#(Fig in Cr.)	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	17	18	20	26	24	47	68	36	36
Other Income	0	1	1	1	3	2	6	1	0
Total Income	18	19	21	27	26	49	74	37	37
Total Expenditure	16	15	17	20	30	29	51	35	33
Operating Profit	2	3	4	7	-3	20	23	2	3
Interest	1	1	2	2	3	2	1	1	0
Depreciation	1	1	2	3	4	4	4	5	4
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	1	0	1	-11	14	18	-4	-3
Provision for Tax	0	0	0	0	-2	2	6	-1	0
Profit After Tax	-0	1	0	1	-9	12	12	-3	-2
Adjustments	0	0	0	0	-0	0	0	0	0
Profit After Adjustments	-0	1	0	1	-9	12	12	-3	-2
Adjusted Earnings Per Share	-0	0.8	0.1	0.7	-5.6	7.7	7.9	-2	-1.9

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-47%	14%	12%	0%
Operating Profit CAGR	-91%	0%	-13%	0%
PAT CAGR	-125%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-10%	-20%	9%	NA%
ROE Average	-7%	21%	7%	6%
ROCE Average	-5%	22%	12%	11%

Jeevan Scientific Balance Sheet

#(Fig in Cr.)	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	4	17	22	32	23	35	51	48
Minority's Interest	0	0	0	0	0	0	0	0
Borrowings	8	5	10	7	8	8	4	4
Other Non-Current Liabilities	-0	-0	0	1	-1	-0	1	2
Total Current Liabilities	8	9	17	21	22	23	22	11
Total Liabilities	20	31	49	61	52	65	78	65
Fixed Assets	9	11	19	20	18	23	19	25
Other Non-Current Assets	1	6	10	16	16	8	5	11
Total Current Assets	11	14	21	25	18	34	54	29
Total Assets	20	31	49	61	52	65	78	65

Jeevan Scientific Cash Flow

#(Fig in Cr.)	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	0	0	1	4	2	6	30
Cash Flow from Operating Activities	4	-6	6	4	-0	5	20	-9
Cash Flow from Investing Activities	-4	-9	-14	-8	-2	-1	-1	-7
Cash Flow from Financing Activities	0	15	10	6	0	-0	6	-7
Net Cash Inflow / Outflow	0	0	1	2	-1	4	24	-23
Closing Cash & Cash Equivalent	0	0	1	4	2	6	30	7

Jeevan Scientific Ratios

#	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-0.01	0.82	0.1	0.73	-5.63	7.67	7.94	-1.98
CEPS(Rs)	1.11	2.14	1.95	2.77	-3.05	10.27	10.22	1.3
DPS(Rs)	0	0	0	0	0	0.5	1.2	0
Book NAV/Share(Rs)	6.24	13.06	16.48	20.8	15.18	22.89	31.34	28.88
Core EBITDA Margin(%)	10.15	16.04	16.92	22.39	-24.33	37.2	24.71	3.74
EBIT Margin(%)	8.58	12.48	11.04	14.25	-30.12	33.89	28.01	-7.32
Pre Tax Margin(%)	1.24	4.75	1.77	5.23	-44.04	29.07	26.59	-10.18
PAT Margin (%)	-0.04	4.16	0.55	4.26	-35.86	25	17.62	-8.47
Cash Profit Margin (%)	3.85	10.88	10.95	16.25	-19.49	33.46	23.06	5.55
ROA(%)	-0.03	2.97	0.28	2.01	-15.11	19.95	16.67	-4.28
ROE(%)	-0.18	9.53	0.72	4.39	-31.19	40.31	28.79	-6.61
ROCE(%)	10.05	11.31	6.81	8.2	-15.82	36.77	35.01	-4.5
Receivable days	151.93	186	247.17	216.5	164.17	82.75	59.37	97.32
Inventory Days	47.86	27.6	5.13	2.3	8.97	17.11	13.22	11.74
Payable days	7292.15	6055.93	604.22	499.43	1032.65	1624.13	129.88	283.16
PER(x)	0	49.38	427.51	39.35	0	7.99	16.35	0
Price/Book(x)	6.22	3.09	2.53	1.38	1.06	2.68	4.14	1.69
Dividend Yield(%)	0	0	0	0	0	0.82	0.92	0
EV/Net Sales(x)	1.97	2.5	3.19	2.23	1.69	2.09	2.68	2.08
EV/Core EBITDA(x)	15.82	13.03	14.9	8.51	-12.3	4.93	8.01	30.95
Net Sales Growth(%)	0	4.76	12	28.09	-8.37	96.12	44.39	-46.63
EBIT Growth(%)	0	52.26	-0.9	65.31	-293.69	320.65	19.36	-113.94
PAT Growth(%)	0	0	-85.24	896.63	-870.74	236.74	1.73	-125.66
EPS Growth(%)	0	7466.68	-88.05	646.35	-872.95	236.35	3.52	-124.87
Debt/Equity(x)	2.94	0.7	0.99	0.57	0.77	0.3	0.26	0.14
Current Ratio(x)	1.32	1.52	1.2	1.16	0.8	1.48	2.42	2.56
Quick Ratio(x)	1.05	1.47	1.19	1.15	0.76	1.33	2.35	2.49
Interest Cover(x)	1.17	1.61	1.19	1.58	-2.16	7.04	19.72	-2.56
Total Debt/Mcap(x)	0.47	0.23	0.39	0.41	0.73	0.11	0.06	0.09

Jeevan Scientific Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	38.11	36.15	36.47	36.47	36.85	38.44	38.48	38.48	38.48	38.7
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	61.89	63.85	63.53	63.53	63.15	61.56	61.52	61.52	61.52	61.3
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.58	0.55	0.56	0.56	0.56	0.6	0.6	0.6	0.6	0.6
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.95	0.98	0.97	0.97	0.97	0.95	0.95	0.95	0.95	0.95
Others	0	0	0	0	0	0	0	0	0	0
Total	1.53	1.53	1.53	1.53	1.53	1.55	1.55	1.55	1.55	1.55

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 21%
Company is almost debt free.

Cons

Promoter holding is low: 38.7%.
Debtor days have increased from 129.88 to 283.16days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.